Ros Wade

1.8k total citations
36 papers, 686 citations indexed

About

Ros Wade is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Ros Wade has authored 36 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Ros Wade's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Ros Wade is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Ros Wade collaborates with scholars based in United Kingdom and Germany. Ros Wade's co-authors include Nerys Woolacott, Claire McKenna, Rita Faria, N Gummerson, Huiqin Yang, Alison Eastwood, Alex J. Sutton, Mark Sculpher, Bob Phillips and Lesley Stewart and has published in prestigious journals such as European Journal of Cancer, Journal of Advanced Nursing and British Journal of Dermatology.

In The Last Decade

Ros Wade

34 papers receiving 673 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ros Wade United Kingdom 14 252 140 102 82 74 36 686
Luit Penninga Denmark 17 676 2.7× 121 0.9× 114 1.1× 35 0.4× 53 0.7× 81 1.1k
Beatriz Díaz‐Molina Spain 20 504 2.0× 150 1.1× 160 1.6× 29 0.4× 22 0.3× 93 1.2k
Susan B. Broy United States 15 578 2.3× 463 3.3× 119 1.2× 122 1.5× 72 1.0× 24 1.5k
Matt Morgan United Kingdom 15 135 0.5× 114 0.8× 142 1.4× 21 0.3× 11 0.1× 61 818
Stephen Kelly United Kingdom 15 156 0.6× 117 0.8× 30 0.3× 25 0.3× 66 0.9× 38 992
Nazan Sarper Türkiye 15 85 0.3× 115 0.8× 87 0.9× 43 0.5× 26 0.4× 72 685
György Lázár Hungary 15 409 1.6× 164 1.2× 63 0.6× 14 0.2× 56 0.8× 119 823
Sébastien Bommart France 16 220 0.9× 111 0.8× 135 1.3× 143 1.7× 105 1.4× 51 898
Muath Bishawi United States 21 1.1k 4.2× 138 1.0× 106 1.0× 39 0.5× 62 0.8× 105 1.6k
Reo Kawano Japan 15 119 0.5× 40 0.3× 106 1.0× 154 1.9× 54 0.7× 72 729

Countries citing papers authored by Ros Wade

Since Specialization
Citations

This map shows the geographic impact of Ros Wade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ros Wade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ros Wade more than expected).

Fields of papers citing papers by Ros Wade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ros Wade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ros Wade. The network helps show where Ros Wade may publish in the future.

Co-authorship network of co-authors of Ros Wade

This figure shows the co-authorship network connecting the top 25 collaborators of Ros Wade. A scholar is included among the top collaborators of Ros Wade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ros Wade. Ros Wade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wade, Ros, Sarah J Nevitt, Melissa Harden, et al.. (2024). Multi-cancer early detection tests for general population screening: a systematic literature review. Health Technology Assessment. 29(2). 1–105. 6 indexed citations
2.
South, Emily, Ros Wade, Sahar Sharif, et al.. (2023). The effectiveness of ablative and non‐surgical therapies for early hepatocellular carcinoma: Systematic review and network meta‐analysis of randomised controlled trials. Cancer Medicine. 12(22). 20759–20772. 2 indexed citations
3.
Walton, Matthew, Robert Hodgson, Alison Eastwood, et al.. (2022). Management of patients presenting to the emergency department with sudden onset severe headache: systematic review of diagnostic accuracy studies. Emergency Medicine Journal. 39(11). 818–825. 9 indexed citations
4.
Claxton, Lindsay, Matthew Walton, Sahar Sharif, et al.. (2021). The Cost-Effectiveness of Selective Internal Radiation Therapies Compared With Sorafenib for Treating Advanced Unresectable Hepatocellular Carcinoma in the United Kingdom. Value in Health. 25(5). 787–795. 2 indexed citations
5.
Walton, Matthew, Ros Wade, Lindsay Claxton, et al.. (2020). Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation. Health Technology Assessment. 24(48). 1–264. 12 indexed citations
7.
Wade, Ros, Alexis Llewellyn, Julie Jones-Diette, et al.. (2018). Interventional management of hyperhidrosis in secondary care: a systematic review. British Journal of Dermatology. 179(3). 599–608. 20 indexed citations
8.
Wade, Ros, Fiona Paton, & Nerys Woolacott. (2017). Surgical patients' adherence to the use of compression stockings. Nursing times. 113(4). 32–33. 3 indexed citations
9.
Wade, Ros, Stephen Rice, Alexis Llewellyn, et al.. (2017). Interventions for hyperhidrosis in secondary care: a systematic review and value-of-information analysis. Health Technology Assessment. 21(80). 1–280. 11 indexed citations
11.
Hinde, Sebastian, Ros Wade, Stephen Palmer, Nerys Woolacott, & Eldon Spackman. (2016). Apremilast for the Treatment of Moderate to Severe Plaque Psoriasis: A Critique of the Evidence. PharmacoEconomics. 34(6). 587–596. 2 indexed citations
12.
Sideris, E.G., et al.. (2015). Ipilimumab for Previously Untreated Unresectable Malignant Melanoma: A Critique of the Evidence. PharmacoEconomics. 33(12). 1269–1279. 12 indexed citations
14.
Wade, Ros, E.G. Sideris, Fiona Paton, et al.. (2015). Graduated compression stockings for the prevention of deep-vein thrombosis in postoperative surgical patients: a systematic review and economic model with a value of information analysis. Health Technology Assessment. 19(98). 1–220. 30 indexed citations
15.
Wade, Ros, Micah Rose, Aileen Neilson, et al.. (2013). Ruxolitinib for the Treatment of Myelofibrosis: A NICE Single Technology Appraisal. PharmacoEconomics. 31(10). 841–852. 13 indexed citations
16.
Phillips, Bob, Ros Wade, Thomas Lehrnbecher, Lesley Stewart, & Alex J. Sutton. (2012). Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer. BMC Medicine. 10(1). 6–6. 60 indexed citations
17.
Wade, Ros, Huiqin Yang, Claire McKenna, et al.. (2012). A systematic review of the clinical effectiveness of EOS 2D/3D X-ray imaging system. European Spine Journal. 22(2). 296–304. 80 indexed citations
18.
Phillips, Bob, et al.. (2011). Systematic review and meta‐analysis of the value of clinical features to exclude radiographic pneumonia in febrile neutropenic episodes in children and young people. Journal of Paediatrics and Child Health. 48(8). 641–648. 8 indexed citations
19.
Phillips, Bob, Ros Wade, Lesley Stewart, & Alex J. Sutton. (2010). Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people. European Journal of Cancer. 46(16). 2950–2964. 45 indexed citations
20.
Booth, Sara & Ros Wade. (2003). Oxygen or air for palliation of breathlessness in advanced cancer. Journal of the Royal Society of Medicine. 96(5). 215–218. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026